e. coli etvax
Vaccineexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 12, 2017 (NCT03729219)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Escherichia coli O157:H7Immunity, active
Escherichia coli O157:H7 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03729219 | Phase 2 | Jun 12, 2017 | Medfiles, Scandinavian Biopharma AB, United Medix Laboratories Ltd., University of Gothenburg, University of Helsinki, University of Virginia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Medfiles | For profit | 1 | 0 | 1 | 2017 |
| Scandinavian Biopharma AB | For profit | 1 | 1 | 1 | 2017 |
| United Medix Laboratories Ltd. | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Gothenburg | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Helsinki | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Virginia | Academic/Hospital | 1 | 0 | 1 | 2017 |
6 organizations
Page 1 / 1